Immitra Bio GmbH
PrivateLast Round
Pre Seed
Jul 21, 2026
Est. Valuation
$22M
Total Funding Raised
$3M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Immitra Bio GmbH is a biotechnology company that develops an in-vivo gene editing platform combining hematopoietic stem cell manipulation and CRISPR-Cas9 technology to treat rare genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Immitra Bio GmbH Comparables
Compare Immitra Bio GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ensoma | 78% | |
| YolTech Therapeutics | 75% | |
| Tessera Therapeutics | 73% |
Immitra Bio GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Jul 21, 2026 |
Immitra Bio GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kickfund | Pre Seed |
| Fongit | Pre Seed |
| BackBone Ventures | Pre Seed |
| ETH Zurich Foundation | Pre Seed |
| Venture Kick | Pre Seed |
| another.vc | Pre Seed |
| OCCIDENT | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 21, 2026
$3M round led by BackBone Ventures and OCCIDENT.
Immitra Bio GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Immitra Bio GmbH's valuation, stock price, and market status.
Is Immitra Bio GmbH a public or private company?
Immitra Bio GmbH is a private company.
What is the current stock price of Immitra Bio GmbH?
Immitra Bio GmbH is a private company with no public stock price. Caplight tracks Immitra Bio GmbH's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Immitra Bio GmbH worth (valuation)?
Valuation information for Immitra Bio GmbH is not publicly available.
Can I buy Immitra Bio GmbH stock?
Immitra Bio GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Immitra Bio GmbH's last funding round?
Immitra Bio GmbH's most recent funding round was Pre Seed on July 21, 2026.
Who are the main investors in Immitra Bio GmbH?
Key investors in Immitra Bio GmbH include BackBone Ventures, OCCIDENT.
Will Immitra Bio GmbH IPO soon?
No public IPO plans have been announced for Immitra Bio GmbH.
How can I track Immitra Bio GmbH secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Immitra Bio GmbH's secondary market activity and sign up for updates.